PT817786E - Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus - Google Patents

Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus

Info

Publication number
PT817786E
PT817786E PT96911227T PT96911227T PT817786E PT 817786 E PT817786 E PT 817786E PT 96911227 T PT96911227 T PT 96911227T PT 96911227 T PT96911227 T PT 96911227T PT 817786 E PT817786 E PT 817786E
Authority
PT
Portugal
Prior art keywords
treatment
uteric
retrovirus
hiv
substitute
Prior art date
Application number
PT96911227T
Other languages
English (en)
Inventor
Suvit Thaisrivongs
Paul Adrian Aristoff
Harvey Irving Skulnick
Linda Louise Maggiora
Robert A Chrusciel
James Michael Tustin
Clark William Smith
Ruben Tommasi
W Jeffrey Howe
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PT817786E publication Critical patent/PT817786E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60Two oxygen atoms, e.g. succinic anhydride
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT96911227T 1995-03-20 1996-03-07 Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus PT817786E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40732295A 1995-03-20 1995-03-20

Publications (1)

Publication Number Publication Date
PT817786E true PT817786E (pt) 2003-06-30

Family

ID=23611540

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96911227T PT817786E (pt) 1995-03-20 1996-03-07 Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus

Country Status (11)

Country Link
US (1) US6060600A (pt)
EP (1) EP0817786B1 (pt)
JP (1) JPH11503416A (pt)
AT (1) ATE232867T1 (pt)
AU (1) AU5417696A (pt)
DE (1) DE69626276T2 (pt)
DK (1) DK0817786T3 (pt)
ES (1) ES2191095T3 (pt)
PT (1) PT817786E (pt)
SI (1) SI0817786T1 (pt)
WO (1) WO1996029333A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
JP3726684B2 (ja) * 2001-01-11 2005-12-14 株式会社Kddi研究所 動画像データ転送における輻輳を回避する通信システム
DE102006039912A1 (de) * 2006-08-25 2008-03-20 Bayer Healthcare Ag Substituierte Spirotetronsäuren und ihre Verwendung
DE102006059319A1 (de) * 2006-12-15 2008-06-19 Bayer Healthcare Ag Substituierte Aminofuranone und ihre Verwendung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production
JP2515556B2 (ja) * 1986-08-29 1996-07-10 武田薬品工業株式会社 ヒドロキシブテノライド誘導体およびその製造法
EP0365329B1 (en) * 1988-10-20 1992-03-18 Shionogi & Co., Ltd. Antibiotics active against anaerobic bacteria, their production and use, and strains of enterobacter producing the same
JP3156006B2 (ja) * 1990-07-30 2001-04-16 武田薬品工業株式会社 テトロン酸誘導体、その製造法及び用途
EP0480624A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. Inhibitors of HIV protease
WO1993004055A2 (en) * 1991-08-27 1993-03-04 The Upjohn Company Compounds used for the inhibition of hiv-protease
EP0534907B1 (en) * 1991-09-26 1998-08-05 Nippon Zoki Pharmaceutical Co., Ltd. The use of furanone derivatives for the prevention or treatment of autoimmune diseases
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
IL108459A0 (en) * 1993-02-05 1994-04-12 Opjohn Company 4-Hydroxy-benzopyran-2-ones and 4-hydroxy-cycloalkyl [B] pyran-2-ones useful for treating infections due to hiv and other retroviruses
JPH09502713A (ja) * 1993-09-17 1997-03-18 ジ・アップジョン・カンパニー Hivおよび他のレトロウイルス病を治療するのに有用な置換テトロン酸

Also Published As

Publication number Publication date
ES2191095T3 (es) 2003-09-01
JPH11503416A (ja) 1999-03-26
US6060600A (en) 2000-05-09
AU5417696A (en) 1996-10-08
EP0817786B1 (en) 2003-02-19
WO1996029333A1 (en) 1996-09-26
DE69626276D1 (de) 2003-03-27
EP0817786A1 (en) 1998-01-14
SI0817786T1 (en) 2003-08-31
ATE232867T1 (de) 2003-03-15
DK0817786T3 (da) 2003-05-26
DE69626276T2 (de) 2003-11-13

Similar Documents

Publication Publication Date Title
MX9700237A (es) Combinaciones inhibidoras de proteasa retroviral.
BR9812837A (pt) Processo para fazer um composto, e, composto
DK0662005T3 (da) Mikropartikelpræparater af biologisk nedbrydelige copolymerer
ATE204164T1 (de) Pflaster zur behandlung von nagelmykosen
EE03969B1 (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
MX9205244A (es) Micelas modificadas de caseina.
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
ES2119185T3 (es) Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad.
BR9509975A (pt) Formulação farmacêutica
DE69831409D1 (de) Chalcon-derivate mit antiproliferativer aktivität
ATE207295T1 (de) Fungizide mischungen
ATE198990T1 (de) Konjugat zur behandlung von entzündlichen erkrankungen
BR9808923A (pt) Composto, e, processo para fazer o mesmo
PT817786E (pt) Acidos tetronicos substituidos uteis para o tratamento do vih e de outros retrovirus
ATE201680T1 (de) 2,3,4,5-tetrahydro-1h-3-benzazepin säure- additions-salze
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
OA08973A (fr) Butyl hydroxyanisoles pour le traitement des maladies à rétro-virus
ES2147601T3 (es) Procedimiento para la preparacion de 3-amino-2-cloro-4-alquil-piridinas o 3-amino-2-cloro-4-cicloalquil-piridinas.
SE9404438D0 (sv) New process
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
ES2140544T3 (es) Utilizacion de efaroxan y de sus derivados para la fabricacion de medicamentos destinados al tratamiento de las enfermedades neurodegenerativas.
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.